Strategic Analysis of the U.S. Biopharmaceuticals Market


USD 4,950.00

* Required Fields

USD 4,950.00


Be the first to review this product

This research service covers the strategic analysis of the U.S. biopharmaceutical market 2004-2014. Included are technology trends, total market revenue forecasts, and selected market segment revenue forecasts. The market is segmented by product class: antisense, cytokines and proteins, enzymes and hormones, gene and cell therapies, and vaccines. Major market challenges, drivers, and restraints and identified and discussed. Also included is selected late stage pipeline analysis.

Table of Contents

Strategic Analysis of the U.S. Biopharmaceuticals Market, Executive SummaryExecutive SummaryIntroductionStrategic Analysis of the U.S. Biopharmaceuticals Market, Market OverviewResearch Scope and MethodologyScope and SegmentationResearch MethodologyMarket IntroductionMarket Engineering MeasurementsIntroductionMain Classes of BiopharmaceuticalsRecent Product ApprovalsCompetitive StructureMarket TrendsHot Topics and TrendsIndustry ChallengesMarket DriversMarket RestraintsPipeline AnalysisIntroductionAntisense TherapiesGene and Cell TherapiesHormones and ProteinsInterferons and InterleukinsMonoclonal AntibodiesVaccinesOthersStrategic Analysis of the U.S. Biopharmaceuticals Market, Revenue AnalysisTotal Market ForecastsRevenue ForecastsSelect Sub Market ForecastsIntroductionMonoclonal Antibodies Market ForecastsHuman Growth Hormone Market ForecastsStrategic Analysis of the U.S. Biopharmaceuticals Market, Decision Support DatabasesOncology DatabasesCancer CasesIncidence of Breast CancerIncidence of Colon and Rectum CancerIncidence of Bladder CancerIncidence of Lung CancerIncidence of Stomach CancerAutoimmune and Inflammatory Disorders DatabasesPrevalence of ArthritisPrevalence of PsoriasisPrevalence of Multiple SclerosisOrgan Transplants DatabasesThe Total Number of Kidney TransplantsTotal Number of Heart TransplantsTotal Number of Liver TransplantsCardiovascular DisordersPrevalence of Cardiovascular DiseasesPrevalence of Coronary Heart DiseaseNew Cases of Heart AttackNeurodegenerative Disorders DatabasesPrevalence of Parkinson's DiseasePrevalence of Alzheimer's DiseasePrevalence of EpilepsyIncidence of StrokeRespiratory Disorders DatabasesPrevalence of AsthmaPrevalence of COPDMiscellaneous DatabasesAge-Related Macular Degeneration PrevalenceIncidence of Diabetes

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.